Dr. Reddy’s Laboratories Ltd.

We are investigating Dr. Reddy’s Laboratories Ltd. (NYSE: RDY) (“Dr. Reddy’s” or the “Company”) on behalf of purchasers of the company’s securities between June 23, 2016 to September 14, 2017 for possible federal securities laws violations.

Join this Action

Dr. Reddy’s Laboratories Ltd. Action

To receive more information regarding the investigation of Dr. Reddy’s Laboratories Ltd. please fill out the form below.

Are you a current or former employee of the company Dr. Reddy’s Laboratories Ltd.?

Plaintiff certifies that:

1.  Plaintiff has reviewed a draft of the complaint and has authorized the filing of a complaint against Dr. Reddy’s Laboratories Ltd. substantially similar to the one reviewed.

2.  Plaintiff selects Monteverde & Associates PC and any firm with which it affiliates for the purpose of prosecuting this action as my counsel for purposes of prosecuting my claim against defendants.

3.  Plaintiff did not purchase the security that is the subject of the complaint at the direction of Plaintiff’s counsel or in order to participate in any private action arising under the federal securities laws.

4.  Plaintiff is willing to serve as a representative party on behalf of a class, including providing testimony at deposition and trial, if necessary.

5.  Plaintiff sets forth in the attached chart all the transactions in the security that is the subject of the complaint during the class period specified in the complaint.

6.  In the past three years, Plaintiff has not sought to serve nor has served as a representative party on behalf of a class in an action filed under the federal securities laws, unless otherwise specified below.

7.  Plaintiff will not accept any payment for serving as a representative party on behalf of a class beyond Plaintiff’s pro rata share of any recovery, except such reasonable costs and expenses (including lost wages) directly relating to the representation of the Class as ordered or approved by the Court.

8.  I have not sought to serve, or served, as a representative party on behalf of a class under the federal security laws during the last three years, except if detailed below.

The Retainer Agreement provided to me is incorporated by reference.

Signed pursuant to California Civil Code Section 1633. 1, et seq. – Uniform Electronic Transactions Act as adopted by the various states and territories of the United States.

Date of Signing: 12/07/2024